Get started Log in

SNT — Syntara Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Market Cap
AU$37.28m
Enterprise Value
AU$23.71m
Revenue
AU$6.84m

Brief: Pharmaxis Says HY Revenue From Sale Of Goods A$1.3 Mln
10/02/2023 05:14
Australia's Pharmaxis eyes worst day in 2 years on discounted placement
19/10/2022 03:22
Brief: Pharmaxis Ltd Seeks Trading Halt
17/10/2022 23:00
Australia's Pharmaxis set for best day in two weeks on clinical phase funding
01/09/2022 04:49
Brief: Pharmaxis To Receive 2.9M EUR From Parkinson's Uk For Phase 2 Parkinson's Disease Clinical Trial
01/09/2022 02:45
Brief: Pharmaxis Ltd Says Aptar Pharma Pays Pharmaxis $5Mln To Acquire Orbital Technology
04/08/2022 09:15
R&D Showcase Presentations Webinar 1
29/03/2022 24:32
Investor Presentation
22/03/2022 03:02
PXS Investor R&D Showcase Webinars
17/03/2022 22:35
PXS Launches New International Trial Sites in Cancer Trial
16/03/2022 21:19
Change in substantial holding
11/02/2022 05:34
PRE_NR Ends: 15:26:12
11/02/2022 04:15
Half Yearly Report and Accounts
11/02/2022 04:15
Updated Investor Presentation
31/01/2022 06:26
Presentation - quarterly investor update
30/01/2022 23:45
PRE_NR Ends: 08:54:31
30/01/2022 21:43
Quarterly Activities Report
30/01/2022 21:43
Quarterly Appendix 4C Cash Flow Report
30/01/2022 21:42
PRE_NR Ends: 08:53:06
30/01/2022 21:42
First Patients Dosed in PXS Scar Reduction Trial
30/01/2022 21:26